 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Aldeyra Therapeutics Inc. (ALDX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-12-16 Purchase | 2019-12-18 07:35 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 20,000 | $5.095 | $101,908 | 652,216 (Direct) | View |
| 2019-09-30 Purchase | 2019-10-02 07:36 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 8,710 | $5.681 | $49,483 | 632,216 (Direct) | View |
| 2019-09-23 Purchase | 2019-09-25 07:40 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 8,680 | $5.81 | $50,433 | 623,506 (Direct) | View |
| 2019-09-18 Purchase | 2019-09-20 07:37 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 14,288 | $5.912 | $84,465 | 614,826 (Direct) | View |
| 2019-09-17 Purchase | 2019-09-19 4:23 pm | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 1,700 | $5.85 | $9,945 | 18,644 (Direct) | View |
| 2019-09-13 Purchase(A) | 2019-09-17 4:21 pm | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 21,547 | $5.915 | $127,449 | 600,538 (Direct) | View |
| 2019-09-13 Purchase | 2019-09-17 07:36 am | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 5,000 | $6 | $30,000 | 85,000 (Direct) | View |
| 2019-09-13 Purchase | 2019-09-17 07:35 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 13,000 | $5.845 | $75,990 | 591,991 (Direct) | View |
| 2019-09-12 Purchase | 2019-09-16 4:15 pm | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 1,700 | $5.861 | $9,964 | 19,644 (Direct) | View |
| 2019-09-11 Purchase | 2019-09-13 07:54 am | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 20,000 | $5.89 | $117,805 | 80,000 (Direct) | View |
| 2019-09-09 Purchase | 2019-09-11 4:05 pm | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 20,000 | $5.141 | $102,824 | 578,991 (Direct) | View |
| 2019-09-09 Purchase | 2019-09-11 4:05 pm | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 20,000 | $4.998 | $99,963 | 60,000 (Direct) | View |
| 2019-09-06 Purchase | 2019-09-10 5:01 pm | Aldeyra Therapeutics Inc. | ALDX | Clark David J Chief Medical Officer | 5,000 | $5.062 | $25,311 | 17,878 (Direct) | View |
| 2019-09-05 Purchase | 2019-09-09 4:38 pm | Aldeyra Therapeutics Inc. | ALDX | Reed Joshua CFO | 3,200 | $4.71 | $15,072 | 35,774 (Direct) | View |
| 2019-09-05 Purchase | 2019-09-09 4:37 pm | Aldeyra Therapeutics Inc. | ALDX | McMullin David Chief Commerical Officer | 4,329 | $4.68 | $20,260 | 6,148 (Direct) | View |
| 2019-03-26 Sale | 2019-03-28 5:10 pm | Aldeyra Therapeutics Inc. | ALDX | TREU JESSE I Director | 96,743 | $10.01 | $968,397 | 8,763 (Indirect) | View |
| 2017-09-19 Purchase | 2017-09-21 08:45 am | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 200,000 | $7.25 | $1,450,000 | 3,085,458 (Indirect) | View |
| 2017-06-30 Purchase | 2017-07-05 5:56 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 296,007 | $4.6 | $1,361,632 | 2,885,458 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-01-13 Option Award | 2020-01-15 5:17 pm | N/A 2030-01-12 | Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director | 24,264 | $6.15 | 24,264 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:41 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 18,951 | $7.06 | 1,102 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:41 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 1,653 | $7.06 | 1,102 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:41 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 1,102 | $7.06 | 1,102 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:36 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director | 18,951 | $7.06 | 2,204 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:36 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director | 2,204 | $7.06 | 2,204 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:36 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 18,951 | $7.06 | 771 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:36 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 6,611 | $7.06 | 771 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:36 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 771 | $7.06 | 771 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:35 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 18,951 | $7.06 | 3,305 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:35 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 771 | $7.06 | 3,305 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:35 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 3,305 | $7.06 | 3,305 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:34 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director | 18,951 | $7.06 | 1,102 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 5:34 pm | N/A 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director | 1,102 | $7.06 | 1,102 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 4:38 pm | 2020-06-04 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | TREU JESSE I Director | 18,951 | $7.06 | 1,653 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 4:38 pm | 2020-06-04 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | TREU JESSE I Director | 1,763 | $7.06 | 1,653 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 4:38 pm | 2020-06-04 2029-06-03 | Aldeyra Therapeutics Inc. | ALDX | TREU JESSE I Director | 1,653 | $7.06 | 1,653 (Direct) | View |
| 2019-03-05 Option Award | 2019-03-07 5:30 pm | N/A 2029-03-04 | Aldeyra Therapeutics Inc. | ALDX | McMullin David Chief Commercial Officer | 45,212 | $8.05 | 45,212 (Direct) | View |
| 2019-03-05 Option Award | 2019-03-07 5:24 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Reed Joshua CFO | 29,637 | $0 | 250,000 (Direct) | View |
| 2019-03-05 Option Award | 2019-03-07 5:24 pm | N/A 2029-03-04 | Aldeyra Therapeutics Inc. | ALDX | Reed Joshua CFO | 250,000 | $8.05 | 250,000 (Direct) | View |
| 2019-03-05 Option Award | 2019-03-07 5:22 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Clark David J Chief Medical Officer | 3,503 | $0 | 250,000 (Direct) | View |
| 2019-03-05 Option Award | 2019-03-07 5:22 pm | N/A 2029-03-04 | Aldeyra Therapeutics Inc. | ALDX | Clark David J Chief Medical Officer | 250,000 | $8.05 | 250,000 (Direct) | View |
| 2019-03-05 Option Award | 2019-03-07 5:20 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 250,000 | $0 | 45,329 (Direct) | View |
| 2019-03-05 Option Award | 2019-03-07 5:20 pm | N/A 2029-03-04 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 250,000 | $8.05 | 45,329 (Direct) | View |
| 2019-03-05 Option Award | 2019-03-07 5:20 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 45,329 | $8.05 | 45,329 (Direct) | View |
| 2018-07-30 Option Award | 2018-08-01 4:46 pm | N/A 2028-07-29 | Aldeyra Therapeutics Inc. | ALDX | Reed Joshua CFO | 75,000 | $6.8 | 75,000 (Direct) | View |
| 2018-06-07 Option Award | 2018-06-11 4:15 pm | 2019-06-07 2028-06-06 | Aldeyra Therapeutics Inc. | ALDX | TREU JESSE I Director | 15,526 | $8.35 | 1,444 (Direct) | View |
| 2018-06-07 Option Award | 2018-06-11 4:15 pm | 2019-06-07 2028-06-06 | Aldeyra Therapeutics Inc. | ALDX | TREU JESSE I Director | 1,354 | $8.35 | 1,444 (Direct) | View |
| 2018-06-07 Option Award | 2018-06-11 4:15 pm | 2019-06-07 2028-06-06 | Aldeyra Therapeutics Inc. | ALDX | TREU JESSE I Director | 1,444 | $8.35 | 1,444 (Direct) | View |
| 2018-06-07 Option Award | 2018-06-08 4:38 pm | N/A 2028-06-06 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 15,526 | $8.35 | 903 (Direct) | View |
| 2018-06-07 Option Award | 2018-06-08 4:38 pm | N/A 2028-06-06 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 1,354 | $8.35 | 903 (Direct) | View |
| 2018-06-07 Option Award | 2018-06-08 4:38 pm | N/A 2028-06-06 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 903 | $8.35 | 903 (Direct) | View |
| 2018-06-07 Option Award | 2018-06-08 4:37 pm | N/A 2028-06-06 | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 15,526 | $8.35 | 632 (Direct) | View |
| 2018-06-07 Option Award | 2018-06-08 4:37 pm | N/A 2028-06-06 | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 5,416 | $8.35 | 632 (Direct) | View |
| 2018-06-07 Option Award | 2018-06-08 4:37 pm | N/A 2028-06-06 | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 632 | $8.35 | 632 (Direct) | View |
| 2018-06-07 Option Award | 2018-06-08 4:36 pm | N/A 2028-06-06 | Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director | 15,526 | $8.35 | 903 (Direct) | View |
| 2018-06-07 Option Award | 2018-06-08 4:36 pm | N/A 2028-06-06 | Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director | 903 | $8.35 | 903 (Direct) | View |
| 2018-06-07 Option Award | 2018-06-08 4:35 pm | N/A 2028-06-06 | Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director | 15,526 | $8.35 | 1,805 (Direct) | View |
| 2018-06-07 Option Award | 2018-06-08 4:35 pm | N/A 2028-06-06 | Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director | 1,805 | $8.35 | 1,805 (Direct) | View |
| 2018-06-07 Option Award | 2018-06-08 4:35 pm | N/A 2028-06-06 | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 15,526 | $8.35 | 2,708 (Direct) | View |
| 2018-06-07 Option Award | 2018-06-08 4:35 pm | N/A 2028-06-06 | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 632 | $8.35 | 2,708 (Direct) | View |
| 2018-06-07 Option Award | 2018-06-08 4:35 pm | N/A 2028-06-06 | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 2,708 | $8.35 | 2,708 (Direct) | View |
| 2018-03-06 Option Award | 2018-03-08 4:40 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 101,269 | $0 | 217,293 (Direct) | View |
| 2018-03-06 Option Award | 2018-03-08 4:40 pm | N/A 2028-03-05 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 217,293 | $8.6 | 217,293 (Direct) | View |
| 2018-03-06 Option Award | 2018-03-08 4:40 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Clark David J Chief Medical Officer | 4,774 | $3.995 | 108,633 (Direct) | View |
| 2018-03-06 Option Award | 2018-03-08 4:40 pm | N/A 2028-03-05 | Aldeyra Therapeutics Inc. | ALDX | Clark David J Chief Medical Officer | 108,633 | $8.6 | 108,633 (Direct) | View |
| 2018-03-06 Option Award | 2018-03-08 4:38 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Tulipano Stephen J CFO | 2,077 | $3.953 | 125,670 (Direct) | View |
| 2018-03-06 Option Award | 2018-03-08 4:38 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Tulipano Stephen J CFO | 3,153 | $3.995 | 125,670 (Direct) | View |
| 2018-03-06 Option Award | 2018-03-08 4:38 pm | N/A 2028-03-05 | Aldeyra Therapeutics Inc. | ALDX | Tulipano Stephen J CFO | 125,670 | $8.6 | 125,670 (Direct) | View |
| 2017-06-08 Option Award | 2017-06-12 5:07 pm | N/A 2027-06-07 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 17,776 | $5.15 | 1,481 (Direct) | View |
| 2017-06-08 Option Award | 2017-06-12 5:07 pm | N/A 2027-06-07 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 2,222 | $5.15 | 1,481 (Direct) | View |
| 2017-06-08 Option Award | 2017-06-12 5:07 pm | N/A 2027-06-07 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 1,481 | $5.15 | 1,481 (Direct) | View |